Sunday, April 19, 2026

Graphitized biochar rewires soil microbes to accelerate pollutant breakdown in rice paddies






Biochar Editorial Office, Shenyang Agricultural University

Geoconductor function of graphitized biochar redirects microbial Fe(III) reduction and stimulates hydroxyl radical production in paddy soil 

image: 

Geoconductor function of graphitized biochar redirects microbial Fe(III) reduction and stimulates hydroxyl radical production in paddy soil

view more 

Credit: Hua Shang, Chao Jia, Song Wu, Ning Chen, Yujun Wang & Xiangdong Zhu





A new study reveals that a specially engineered form of biochar can dramatically enhance the natural ability of soil microbes to break down pollutants in rice paddies, offering a promising strategy for cleaner and more sustainable agriculture.

Researchers have developed a highly conductive “graphitized biochar” that acts as an electronic bridge in soil, enabling faster and more efficient interactions between microorganisms and iron minerals. This process boosts the formation of highly reactive molecules that can degrade harmful contaminants such as antibiotics.

“By improving the electrical properties of biochar, we found a way to fundamentally change how electrons move through soil systems,” said the study’s corresponding author. “This allows microbes to work more efficiently, ultimately accelerating pollutant removal in agricultural environments.”

Rice paddies are known to accumulate organic pollutants, including antibiotics from manure and irrigation water. These contaminants can persist in soils at levels exceeding natural degradation capacity. One key pathway for breaking them down involves hydroxyl radicals, highly reactive molecules that can rapidly oxidize pollutants. However, the production of these radicals depends on microbial processes that are often limited by inefficient electron transfer.

To address this challenge, the research team used a rapid heating technique known as flash Joule heating to transform conventional biochar into a more graphitized structure. This modification increased the material’s electrical conductivity by more than twofold, enabling it to function as a “geoconductor” that facilitates long-range electron transport in soil.

Laboratory experiments showed that this graphitized biochar significantly enhanced microbial iron reduction, a key step in generating reactive species. Compared to untreated conditions, the modified biochar increased the production of reactive iron species by nearly 19 percent and boosted hydroxyl radical formation by more than 50 percent.

As a result, the degradation rate of the antibiotic sulfamethoxazole improved substantially, with removal efficiencies reaching complete degradation under experimental conditions. In contrast, soils without the modified biochar showed much lower pollutant removal.

The study also found that the material reshaped soil microbial communities. Beneficial bacteria capable of reducing iron became more abundant, creating a positive feedback loop that further enhanced electron transfer and pollutant breakdown.

Importantly, the effectiveness of the graphitized biochar varied across different soil types, depending on the native microbial community and soil properties. Soils with more active microbial populations showed the greatest improvements, highlighting the importance of biological factors in environmental remediation.

Beyond its immediate application in pollutant removal, the research challenges long-standing assumptions about how biochar functions in soil. Traditionally, biochar has been viewed as an “electron reservoir” that stores and releases electrons through surface chemical groups. This study demonstrates that its role as an electron conductor may be even more critical.

“Our findings suggest that facilitating direct electron transfer, rather than simply storing electrons, is the key to unlocking biochar’s full potential in soil remediation,” the authors noted.

The results open new avenues for designing advanced carbon-based materials that work in harmony with natural microbial processes. Such approaches could help reduce contamination risks in agricultural systems while supporting sustainable soil management practices.

As global concerns grow over soil pollution and antibiotic residues in food production, innovations like graphitized biochar may offer scalable solutions that harness the power of both materials science and microbiology.

 

=== 

Journal Reference: Shang, H., Jia, C., Wu, S. et al. Geoconductor function of graphitized biochar redirects microbial Fe(III) reduction and stimulates hydroxyl radical production in paddy soil. Biochar 8, 92 (2026).   

https://doi.org/10.1007/s42773-026-00597-w   

=== 

About Biochar

Biochar (e-ISSN: 2524-7867) is the first journal dedicated exclusively to biochar research, spanning agronomy, environmental science, and materials science. It publishes original studies on biochar production, processing, and applications—such as bioenergy, environmental remediation, soil enhancement, climate mitigation, water treatment, and sustainability analysis. The journal serves as an innovative and professional platform for global researchers to share advances in this rapidly expanding field. 

Follow us on FacebookX, and Bluesky.  

 

‘Tis the season: Sharing resources sustains ocean microbial biodiversity




University of Hawaii at Manoa
Water sampler 

image: 

A view of the rosette water sampler as it ascends toward the surface to collect samples. 

view more 

Credit: Hawai'i Ocean Time-series





Oceanographers from the University of Hawai‘i at Mānoa discovered that microbial communities–from the sunlit surface to extreme depths–in the North Pacific Subtropical Gyre exhibit robust seasonal cycles. The study provides new insight into how high levels of biodiversity are maintained in the open ocean. 

“A long-standing question in biological oceanography, which we refer to as the “paradox of the plankton”, asks: How can open ocean species diversity be so vast and sustained, in a seemingly homogeneous environment like the open ocean?,” said Fuyan Li, lead author of the study and affiliate researcher in the Center for Microbial Oceanography: Research and Education in the UH Mānoa School of Ocean and Earth Science and Technology (SOEST).

The blue, deep waters of the Pacific Ocean have extremely low nutrient concentrations compared to coastal areas that teem with visible life, such as kelp forests off California or coral reefs in Hawai‘i. 

“Theoretical ecology suggests that one way co-occurring species diversity can be maintained, is if shared resources, such as nutrients, are used at different times of year, thereby minimizing competition,” Li shared. “Though seasonal cycles are a fundamental property of many diverse ecosystems, seasonality in the tropics is less pronounced than in temperate or polar ocean habitats.”  

Tracking microbes through DNA

To determine whether microbial communities at Station ALOHA, a tropical, open ocean research station 60 miles north of O‘ahu, Hawai‘i, have seasonal cycles, Li and colleagues analyzed microbial DNA in samples collected monthly over eight years. The combination of frequent sampling over a long time period, and high-resolution species identification, allowed the researchers to make these new and unprecedented open ocean observations. 

They found that more than 60% of the microbial groups they tracked exhibited seasonal cycling. While these seasonal cycles diminished at depths below 150 meters, surprisingly, they remained measurable in some deep-sea microbial species at depths of nearly two and a half miles. 

“Notably, very closely related species or subspecies “bloomed” at different times of the year, similar to seasonal patterns observed in some terrestrial plants and animals,” Li said. “Taking turns with respect to nutrient use throughout the year seems to be a key ecological strategy for microbial communities to maintain their diversity.”

By sustaining their populations throughout the year, microbial communities consistently supply organic matter and energy to organisms higher in the food web, for example larval fish. In this way, microbes ensure the stability of the marine food web and productivity in waters across the Pacific Ocean.


Nighttime sampling operations 

Researchers deployed a rosette water sampler to colllect water from the surface to the deepest depths at Station ALOHA, 60 miles north of O‘ahu, Hawai‘i.

Credit

Fuyan Li, University of Hawai‘i at Mānoa


 

US Measles vaccine gaps persist among ER patients



Study highlights need to expand vaccination education beyond primary care



University of California - Riverside

Alexandra Eftimie, Robert Rodriguez, Sahithi Malireddy 

image: 

Photo shows (L to R) Alexandra Eftimie, Robert Rodriguez, and Sahithi Malireddy.

view more 

Credit: UC Riverside School of Medicine.






RIVERSIDE, Calif. -- Measles remains one of the most contagious infectious diseases, spread through coughing and sneezing, with even small declines in vaccination coverage leading to outbreaks. As of 2026, California has reported its highest annual measles case count in seven years. In response to this growing concern, researchers have begun examining gaps in measles-related knowledge and vaccination coverage.

A UC Riverside-led study has found critical gaps in knowledge, vaccination status, and acceptance of the measles, mumps, and rubella (MMR) vaccine among patients visiting emergency departments across the United States.

Published in the American Journal of Emergency Medicine, the study examines how misinformation and access barriers may contribute to declining vaccination rates, raising concerns amid ongoing measles outbreaks.

“We found that a substantial portion of emergency department patients lack accurate knowledge about measles and the MMR vaccine,” said medical student Alexandra Eftimie, the paper’s co-lead author. “Many participants were either unsure of their vaccination status or reported not receiving the vaccine at all. Additionally, vaccine hesitancy, driven by misconceptions about safety and necessity, remains a persistent issue.”

Using survey data  (April–December 2024) from 2,459 adult patients across ten U.S. emergency departments, the study evaluated MMR vaccination status, knowledge, and willingness to receive the vaccine among a diverse population. 

“We identified key disparities in under-vaccination associated with factors such as race, language, insurance status, and access to primary care,” said Sahithi Malireddy, an undergraduate student in neuroscience and the paper’s co-lead author. “These disparities specifically emphasized how systemic barriers shape both access to vaccines and health literacy among diverse populations.” 

The researchers stress that their findings demonstrate how emergency departments can serve as critical “safety net” points of care for underserved populations who may not be able to access vaccines/healthcare in traditional formats. 

“This really offers healthcare systems an opportunity to leverage emergency departments not only for emergent care, but also as spaces to deliver accessible, evidence-based public health interventions and improve vaccine equity,” Malireddy said. “By leveraging emergency departments as points of intervention, healthcare systems may be able to reach individuals who would otherwise fall through the cracks of preventive care.”

The researchers were surprised by how often patients lacked access to clear, reliable information. 

“Many gaps stem from systemic barriers like limited literacy tools, language differences, insurance issues, and stigma,” Malireddy said. “They show how culture and access shape responses to symptoms, shifting focus from individual misunderstanding to structural inequities — and underscoring our responsibility to make healthcare knowledge accessible and actionable for marginalized communities.”

Senior author Dr. Robert Rodriguez, a professor of medicine in the UCR School of Medicine, outlined practical, low-burden steps emergency departments can take to boost MMR vaccination rates.

“While most emergency departments may not be able to administer MMR vaccines, they can still serve as high-impact sites for screening and education—especially for underserved populations,” he said. “They can inform patients about the importance of the MMR vaccine and direct them to accessible options, such as clinics and pharmacies, where they can receive it.”

Rodriguez, Eftimie, and Malireddy were joined in the study by researchers at UC San Francisco, UCLA, Rush University Medical Center, Wayne State University, Thomas Jefferson University Hospital, and Duke University School of Medicine.

The title of the paper is “Gaps in knowledge, receipt, and acceptance of measles, mumps, rubella vaccines in a national sample of emergency department patients.”

The University of California, Riverside is a doctoral research university, a living laboratory for groundbreaking exploration of issues critical to Inland Southern California, the state and communities around the world. Reflecting California's diverse culture, UCR's enrollment is more than 26,000 students. The campus opened a medical school in 2013 and has reached the heart of the Coachella Valley by way of the UCR Palm Desert Center. The campus has an annual impact of more than $2.7 billion on the U.S. economy. To learn more, visit www.ucr.edu.

 

Maternal RSV vaccination cuts infant hospitalization risk by over 80%, major UKHSA study finds



The largest real-world study of its kind shows that maternal vaccination against respiratory syncytial virus (RSV) reduces the risk of hospitalisation in young infants by over 80% when given at least two weeks before birth.



Beyond







(Saturday, 18 April 2026, Munich, Germany) The largest real-world study of its kind, presented today at ESCMID Global 2026, shows that maternal vaccination against respiratory syncytial virus (RSV) reduces the risk of hospitalisation in young infants by over 80% when given at least two weeks before birth.1

RSV is a common virus that can cause severe respiratory illness in infants and young children, including lower respiratory tract infections (LRTIs) such as bronchiolitis and pneumonia.2,3 It is a leading cause of infant hospitalisation worldwide, with early-life infection linked to potential longer-term effects including recurrent wheeze or asthma, repeat hospital admissions and impaired lung health.4, 5, 6

In England, a national maternal RSV vaccination programme was introduced on 1 September 2024, offering the Bivalent Prefusion F vaccine to pregnant women from 28 weeks’ gestation.

To evaluate its impact on infant hospitalisations due to RSV-associated LRTI, researchers from the UK Health Security Agency (UKHSA) conducted a retrospective cohort study using linked national datasets, including NHS maternity records, immunisation data and hospital and laboratory data. The analysis included 289,399 infants born between 2 September 2024 and 24 March 2025, representing around 90% of births in England during this period.

Across the study population, 4,594 RSV-associated hospitalisations were recorded. Although infants born to unvaccinated mothers made up 55% of the total cohort, they accounted for 87.2% of hospitalisations.

In contrast, infants whose mothers were vaccinated at least 14 days before birth had a markedly lower risk of hospitalisation, with vaccine effectiveness estimated at 81.3%, relative to the unvaccinated group.

Lead author and UKHSA epidemiologist Matt Wilson commented, “As the largest study to date examining the impact of this vaccine on infant hospitalisation, these findings provide robust evidence that vaccination offers substantial protection against severe illness in young infants. We found a clear relationship between timing and protection, with effectiveness increasing as the interval between vaccination and birth lengthens, reaching close to 85% when vaccination occurs at least four weeks before delivery.”

He continued, “While at least two weeks are typically needed for optimal protection, infants born 10 to 13 days after vaccination had around 50% fewer hospital admissions compared with those whose mothers were unvaccinated, whereas no reduction was seen when vaccination occurred less than 10 days before birth. This reinforces the importance of vaccinating as early as possible within the recommended window, while also showing that even when given later in pregnancy, some protection is still possible from around 10 days before birth, although earlier vaccination remains preferable.”

The study also investigated outcomes in preterm infants. Vaccine effectiveness was estimated at 69.4% in preterm infants, when allowing at least 14 days between vaccination and birth.  

“These findings are particularly important for preterm infants, who are among the most vulnerable to severe RSV infection,” added Wilson. “With sufficient time between vaccination and birth, we saw good levels of protection in these babies. Giving the vaccination early in the third trimester, as recommended by the World Health Organization, could protect most preterm infants.”

Looking ahead, Wilson said that further work is needed to assess the impact of the maternal RSV vaccination programme on infant hospitalisations at a population level and to better understand how protection changes later in infancy. He added that UKHSA will be looking at maternal vaccination and monoclonal antibody immunisation effectiveness in very preterm infants, for whom both are recommended.

He also emphasised the potential for wider global impact, explaining, “While survival from RSV bronchiolitis is high in high-income countries, it remains a major cause of infant mortality in low- and middle-income countries. These findings underscore the potential benefits of wider rollout of maternal RSV vaccination globally in line with the World Health Organization’s recommendations.”

ENDS

Notes to editors:

A reference to ESCMID Global must be included in all coverage and/or articles associated with this study. 

For more information or to arrange an expert interview, please contact the ESCMID Press Office at: communication@escmid.org

About the study author:

Matt Wilson is an epidemiologist working in the Immunisation and Vaccine Preventable Diseases division at the UK Health Security Agency and is a member of the NIHR Health Protection Research Unit in Vaccines and Immunisation. He has an MSc in Epidemiology from the London School of Hygiene and Tropical Medicine.

About the European Society of Clinical Microbiology and Infectious Diseases:

The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) is the leading society for clinical microbiology and infectious diseases in Europe. ESCMID is proud to unite over 13,500 members as well as 45,000 affiliated members through 77 national and international affiliated societies. ESCMID’s mission is to champion medical progress in infection for a healthier tomorrow and plays an important role in emerging infectious diseases and antimicrobial resistance education and research.

Website: www.escmid.org/

References:

  1. Wilson, M., Whitaker, H., Walker, J., et al. (2026). Maternal RSV vaccination and reduced risk of hospitalisation for babies in England – 2024/45. Oral presentation. ESCMID Global 2026.
  2. Munro, A. P. S., Martinón-Torres, F., Drysdale, S.B. et al. (2023). The disease burden of respiratory syncytial virus in Infants. Current Opinion in Infectious Diseases. 36(5):379-384.
  3. European Lung Foundation (ELF). (n.d.). Acute lower respiratory infections. https://europeanlung.org/en/information-hub/lung-conditions/acute-lower-respiratory-infections/
  4. World Health Organization. (n.d.). Global Influenza Programme: Respiratory Syncytial Virus Surveillance. https://www.who.int/teams/global-influenza-programme/global-respiratory-syncytial-virus-surveillance
  5. World Health Organization. (2025). WHO outlines recommendations to protect infants against RSV – respiratory syncytial virus. https://www.who.int/news/item/30-05-2025-who-outlines-recommendations-to-protect-infants-against-rsv-respiratory-syncytial-virus
  6. World Health Organization. (2025). Respiratory syncytial virus (RSV). https://www.who.int/news-room/fact-sheets/detail/respiratory-syncytial-virus-(rsv)#:~:text=Respiratory%20syncytial%20virus%20(RSV)%20is,access%20to%20supportive%20medical%20care.